Key result
Ethanol concentrations of 35% or higher for at least 4 hours reduced mature Candida albicans biofilm metabolic activity by >99% and prevented regrowth in vitro.
Why the study?
Does ethanol reduce Candida albicans biofilm metabolic activity and formation in vitro?
Does ethanol reduce Candida albicans biofilm metabolic activity and formation in vitro?
Ethanol at concentrations of 35% or higher for at least 4 hours effectively reduces mature Candida albicans biofilm metabolic activity by >99% in vitro, supporting its potential use in lock therapy.
Answers are grounded in this paper and cite their sources.
Supports ethanol lock therapy investigation for catheter candidiasis; leaves open clinical translation and safety.
Candida albicans is a common cause of catheter-related bloodstream infections (CR-BSI). Ethanol (EtOH) lock therapy has been attempted despite limited data on optimal dose and duration. Concentrations of 35% EtOH or higher for a minimum of 4 h demonstrated a >99% reduction in mature C. albicans biofilm metabolic activity and prevented regrowth. Concentrations of 10% EtOH or higher reduced C. albicans biofilm formation by >99%. Further investigation of EtOH lock therapy for treatment and prevention of C. albicans CR-BSI is warranted.
No takes yet. Share an insight, caveat, or question.
Rane et al. (2012) studied Candida albicans biofilms. Ethanol (EtOH) was evaluated on Reduction in mature C. albicans biofilm metabolic activity and prevention of regrowth. Ethanol concentrations of 35% or higher for at least 4 hours reduced mature Candida albicans biofilm metabolic activity by >99% and prevented regrowth in vitro.
Synapse has enriched 10 related papers. Consider them for comparative context: